INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
INVO Fertility, Inc. (formerly NAYA Biosciences, Inc.), a Nevada corporation, filed this Current Report on Form 8-K on April 30, 2025. The filing serves to announce the issuance of a press release detailing financial results for the period ended December 31, 2024. The company's common stock trades on The Nasdaq Stock Market LLC under the symbol "IVF."
Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that these results are contained within Exhibit 99.1 (the Press Release dated April 30, 2025), which is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Material Changes
No material changes versus prior periods are detailed in the text of this Form 8-K. The filing references the announcement of full-year 2024 results but does not summarize the specific variances or trends within this document.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information in Item 2.02 and Exhibit 99.1 shall not be incorporated by reference into other Company filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific financial figures for the year ended December 31, 2024, by reviewing Exhibit 99.1 (Press Release) attached to this filing.
- Confirm the company's name change from NAYA Biosciences, Inc. to INVO Fertility, Inc.
- Note that the financial data referenced in this 8-K is not legally "filed" under Section 18 of the Exchange Act, limiting its incorporation by reference in future filings.
- Check the company's liquidity position and cash burn rate in the full press release, as these are not summarized in the 8-K text.